Fidelity Builds a 4.94% Position in Renk as Defense Stock Trades Near 52-Week Lows Ahead of AGM

Renk Group’s shares have shed nearly 44% from their 52-week peak, closing at €49.99 even as the company books record new orders and guides for double-digit earnings growth. That stark disconnect between operational momentum and market valuation is attracting institutional attention. FMR LLC, the parent of Fidelity Investments, disclosed a 4.94% voting rights stake as of 20 May 2026, while Fidelity Advisor Series VIII holds a direct 3.23% position. The filings, required under Section 33 of the German Securities Trading Act, mark a notable shift in the shareholder register: the old anchor investor KNDS has been reducing its holding, handing the baton to a long-term asset manager known for betting on industrial fundamentals.

The focus now turns to Renk’s annual general meeting on 10 June, where shareholders will vote on three pivotal items. The board is proposing a dividend of €0.58 per share, a 38% increase from last year’s €0.42, equating to a payout ratio of roughly 41% of adjusted net profit. The ex-dividend date is set for 11 June, with payment on 15 June. More consequential for the corporate structure is a proposed control and profit transfer agreement between RENK Group AG and its wholly owned subsidiary RENK GmbH — a move that will fundamentally reshape intra-group cash flows and give the AGM far more weight than a routine dividend vote.

Supervisory board chairman Claus von Hermann is stepping down, and Dr. Klaus Richter has been nominated as his successor. Richter, a former CEO of Diehl Gruppe with 12 years of leadership experience at Airbus, most recently as Chief Procurement Officer, is seen by analysts as a signal that Renk is professionalising its governance for a more competitive defence market.

Should investors sell immediately? Or is it worth buying Renk?

Under the hood, the group’s operating performance is hard to fault. First-quarter 2026 order intake hit a historic high of €582.3 million, lifting the total order backlog to roughly €6.9 billion. More than 90% of the planned 2026 revenue is already covered by firm orders or framework agreements. Management has confirmed full-year guidance: revenue above €1.5 billion and adjusted EBIT in a range of €255 million to €285 million. By 2030, the target is to grow revenue to between €2.8 billion and €3.2 billion with an adjusted EBIT margin above 20%.

Yet the stock has been stuck in a technical no-man’s land, with the relative strength index at 47.2 — neither oversold nor overbought. The 50-day moving average of €51.50 and the 200-day average of €59.10 both sit above the current price, reinforcing the bearish undertow. The broader defence sector has taken a hit from renewed peace hopes in the Middle East and signals of a war turning point in Ukraine, casting a shadow over the entire arms-making peer group.

Renk faces its own specific headwind. An export embargo temporarily halted deliveries to Israel, though the restriction has now been lifted and the company expects to resume shipments in the second quarter. The pause shifted roughly €200 million in revenue into the first half of 2026 — a timing issue rather than a loss of demand, but it has dented quarterly momentum. Separate geopolitical uncertainty could still threaten up to €100 million in additional sales this year, depending on how export restrictions evolve.

The AGM on 10 June will test whether the board can convince the market that record order intake will translate into sustained cash flow. With Fidelity now on board and a restructured corporate vehicle taking shape, the pieces for a re-rating are in place — but the stock still needs proof of execution.

Ad

Renk Stock: New Analysis - 3 June

Fresh Renk information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Renk analysis...

en | DE000RENK730 | FIDELITY | boerse | 69475110 |